 Krista Eschbach
Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 17 | 2025 | 102 | 3.970 |
Why?
| | Status Epilepticus | 11 | 2025 | 50 | 3.490 |
Why?
| | Epilepsies, Myoclonic | 4 | 2020 | 51 | 1.840 |
Why?
| | Epilepsy | 11 | 2024 | 333 | 1.490 |
Why?
| | Seizures, Febrile | 4 | 2024 | 21 | 1.320 |
Why?
| | Anticonvulsants | 5 | 2025 | 217 | 0.920 |
Why?
| | Gastrointestinal Diseases | 1 | 2025 | 209 | 0.810 |
Why?
| | Electroencephalography | 8 | 2024 | 423 | 0.750 |
Why?
| | Seizures | 11 | 2025 | 426 | 0.690 |
Why?
| | Neurology | 1 | 2021 | 113 | 0.640 |
Why?
| | Dioxolanes | 1 | 2019 | 6 | 0.620 |
Why?
| | Patient Admission | 1 | 2021 | 197 | 0.620 |
Why?
| | Developmental Disabilities | 2 | 2020 | 263 | 0.590 |
Why?
| | Brain Waves | 1 | 2018 | 33 | 0.580 |
Why?
| | Nervous System Diseases | 1 | 2021 | 266 | 0.580 |
Why?
| | Patient Safety | 1 | 2021 | 314 | 0.560 |
Why?
| | Thyrotropin | 1 | 2017 | 114 | 0.540 |
Why?
| | Caregivers | 1 | 2024 | 877 | 0.530 |
Why?
| | Epileptic Syndromes | 4 | 2024 | 84 | 0.510 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 319 | 0.470 |
Why?
| | Quality of Life | 4 | 2025 | 2892 | 0.460 |
Why?
| | Child | 24 | 2025 | 21935 | 0.460 |
Why?
| | Diet, Ketogenic | 3 | 2024 | 37 | 0.430 |
Why?
| | Testosterone | 1 | 2017 | 409 | 0.420 |
Why?
| | Telemedicine | 1 | 2021 | 862 | 0.380 |
Why?
| | Encephalitis | 2 | 2025 | 136 | 0.360 |
Why?
| | Child, Preschool | 15 | 2025 | 11074 | 0.340 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2069 | 0.320 |
Why?
| | Adolescent | 13 | 2025 | 21513 | 0.290 |
Why?
| | Registries | 3 | 2025 | 2035 | 0.290 |
Why?
| | Humans | 31 | 2025 | 137585 | 0.240 |
Why?
| | Infant | 9 | 2024 | 9465 | 0.240 |
Why?
| | Prodromal Symptoms | 1 | 2025 | 15 | 0.230 |
Why?
| | Male | 16 | 2025 | 67762 | 0.230 |
Why?
| | Female | 17 | 2025 | 73304 | 0.220 |
Why?
| | Young Adult | 8 | 2025 | 13209 | 0.220 |
Why?
| | Databases, Factual | 3 | 2024 | 1357 | 0.220 |
Why?
| | Psychosurgery | 1 | 2023 | 8 | 0.220 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2024 | 80 | 0.220 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2024 | 16 | 0.210 |
Why?
| | Retrospective Studies | 9 | 2025 | 15657 | 0.200 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 2021 | 253 | 0.200 |
Why?
| | Fever | 1 | 2024 | 306 | 0.190 |
Why?
| | Genetic Testing | 2 | 2022 | 460 | 0.190 |
Why?
| | Laser Therapy | 1 | 2023 | 130 | 0.190 |
Why?
| | GABA Modulators | 1 | 2021 | 12 | 0.180 |
Why?
| | Deep Brain Stimulation | 1 | 2024 | 153 | 0.180 |
Why?
| | Interviews as Topic | 1 | 2024 | 786 | 0.180 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 2 | 2019 | 17 | 0.180 |
Why?
| | Palliative Care | 2 | 2024 | 758 | 0.170 |
Why?
| | Cerebral Palsy | 1 | 2022 | 107 | 0.170 |
Why?
| | Middle Aged | 8 | 2025 | 33479 | 0.160 |
Why?
| | Spasms, Infantile | 1 | 2021 | 123 | 0.160 |
Why?
| | Adult | 9 | 2025 | 37929 | 0.160 |
Why?
| | Immunotherapy | 1 | 2024 | 641 | 0.160 |
Why?
| | Drug Approval | 1 | 2019 | 88 | 0.150 |
Why?
| | Lennox Gastaut Syndrome | 1 | 2018 | 17 | 0.150 |
Why?
| | Communication | 1 | 2024 | 879 | 0.150 |
Why?
| | Cytokines | 1 | 2025 | 2085 | 0.130 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5472 | 0.130 |
Why?
| | Cohort Studies | 4 | 2020 | 5742 | 0.130 |
Why?
| | Body Height | 1 | 2017 | 199 | 0.130 |
Why?
| | Follow-Up Studies | 1 | 2025 | 5131 | 0.120 |
Why?
| | Inflammation | 1 | 2025 | 2837 | 0.110 |
Why?
| | Treatment Outcome | 6 | 2025 | 10811 | 0.110 |
Why?
| | Body Weight | 1 | 2017 | 985 | 0.100 |
Why?
| | Mutation | 3 | 2021 | 3958 | 0.100 |
Why?
| | Quality Improvement | 1 | 2021 | 1178 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2024 | 6079 | 0.070 |
Why?
| | Risk Factors | 1 | 2021 | 10388 | 0.070 |
Why?
| | Aged | 4 | 2025 | 23961 | 0.060 |
Why?
| | Atrophy | 1 | 2025 | 184 | 0.060 |
Why?
| | Florida | 1 | 2024 | 107 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2023 | 71 | 0.050 |
Why?
| | Video Recording | 1 | 2024 | 180 | 0.050 |
Why?
| | Rituximab | 1 | 2024 | 176 | 0.050 |
Why?
| | Probability | 1 | 2023 | 304 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3566 | 0.050 |
Why?
| | Neurosurgical Procedures | 1 | 2024 | 197 | 0.050 |
Why?
| | Subdural Space | 1 | 2021 | 8 | 0.050 |
Why?
| | Preoperative Care | 1 | 2024 | 362 | 0.050 |
Why?
| | Stereotaxic Techniques | 1 | 2021 | 39 | 0.050 |
Why?
| | Neuroimaging | 1 | 2023 | 259 | 0.040 |
Why?
| | Infectious Encephalitis | 1 | 2020 | 2 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 143 | 0.040 |
Why?
| | Electrodes, Implanted | 1 | 2021 | 109 | 0.040 |
Why?
| | Valproic Acid | 1 | 2020 | 48 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2021 | 39 | 0.040 |
Why?
| | Potassium Channels | 1 | 2021 | 151 | 0.040 |
Why?
| | Animals | 2 | 2021 | 36940 | 0.040 |
Why?
| | Internet | 1 | 2025 | 655 | 0.040 |
Why?
| | Prospective Studies | 2 | 2023 | 7604 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 628 | 0.040 |
Why?
| | Family | 1 | 2024 | 671 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2021 | 205 | 0.040 |
Why?
| | Physician-Patient Relations | 1 | 2024 | 548 | 0.040 |
Why?
| | DNA Polymerase gamma | 1 | 2019 | 8 | 0.040 |
Why?
| | Cannabinoids | 1 | 2021 | 161 | 0.040 |
Why?
| | Neural Cell Adhesion Molecules | 1 | 2019 | 32 | 0.040 |
Why?
| | Cell Adhesion Molecules, Neuronal | 1 | 2019 | 41 | 0.040 |
Why?
| | Glucose Transporter Type 1 | 1 | 2019 | 50 | 0.040 |
Why?
| | Cannabidiol | 1 | 2021 | 119 | 0.040 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2024 | 804 | 0.040 |
Why?
| | Activities of Daily Living | 1 | 2021 | 413 | 0.040 |
Why?
| | Family Health | 1 | 2019 | 196 | 0.030 |
Why?
| | Receptors, GABA-A | 1 | 2019 | 142 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2019 | 218 | 0.030 |
Why?
| | Anxiety | 1 | 2025 | 1035 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3295 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1050 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 596 | 0.030 |
Why?
| | Brain | 1 | 2025 | 2668 | 0.030 |
Why?
| | Phenotype | 1 | 2021 | 3196 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1502 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5778 | 0.020 |
Why?
|
|
Eschbach's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|